CaroGen Highlights
Developed novel AVIDIO platform
that delivers multiple transgenes
Artificial Virus for Infectious
Diseases &
Immuno-Oncology
Two candidates in late stage pre-clinical (IND enabling) studies
CARG-2020 for ovarian cancer; CARG-201 for Chronic Hepatitis B
Broad and expanding patent portfolio
Issued composition of matter and methods of use patents
HBV program supported by over $10 million in NIH & DoD grants
Expect continued support for Phase 1 clinical studies
Our Team
Founders
Bijan Almassian, phD
Chief Executive Officer
Valerian Nakaar, PhD
Chief Scientific Officer
John Rose, PhD
Chairman
Scientific Advisory Board
Michael Robek, PhD
Member
Scientific Advisory Board